Stalevo

Medicinal product

(Invented) name

Stalevo

Active substance (s)

Levodopa/Karbidopa/Entakaponas

Strength

150 mg/37,5 mg/200 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

N04BA03, Levodopa, decarboxylase inhibitor and COMT inhibitor

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2026-08-20

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

CR-Lygiagretus platinimas

Qualitative and quantitative composition

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122379	108492	1108492	buteliukas	N100		Receptinis	EU/1/03/260/011	Netiekiama	-	2026-12-31	No	-	-

Stadijos

Data	Stadija
2026-08-20	Registruotas